In partnership with
How does this keep happening?
We haven't even finished talking about how huge Gemma 4 is going to be...
And now we just got Qwen 3.6 35B -- a new unbelievably tiny open-weight model that's massively superior to Gemma 4 in so many crucial areas.
And it's blown up massively -- trillions of tokens processed just days after its release.
This thing absolutely destroyed Gemma 4 in several coding benchmarks -- it's not even close... wow.
And still FREE of course.
While Gemma 4 delivers a polished conversational experience, the Qwen 3.6-35B-A3B model effectively outclasses it in software engineering by solving 73.4% of real-world GitHub issues compared to Gemma’s 52.0% on the SWE-bench Verified leaderboard.
For those of you who don't know SWE-bench is one of the most highly trusted benchmarks out there... just imagine.
And this 73.4 is so incredibly close to what Opus 4.6 scored.
Can you believe this?
This ridiculously tiny model that can run on your PC -- is giving that super-computer-data-center-powered beast a dead serious run for it's money.
Imagine how powerful this Qwen is going to be on the next release -- and the next and the next...
And don't get me started on all the other notable features like the shocking speed, the massive context... like what is this?
Gemma 4 is still struggling to get past 300K -- Qwen supports a whopping 1 MILLION token context!
We've literally never seen an open-weight with this sort of intelligence, have this sort of processing bandwidth, it's just incredible.
1. The most efficient model ever made
Yes -- the internal design that made Gemma 4 so efficient -- Qwen 3.6 takes that design to its extreme limits
It has…
1,000+ Proven ChatGPT Prompts That Help You Work 10X Faster
ChatGPT is insanely powerful.
But most people waste 90% of its potential by using it like Google.
These 1,000+ proven ChatGPT prompts fix that and help you work 10X faster.
Sign up for Superhuman AI and get:
1,000+ ready-to-use prompts to solve problems in minutes instead of hours—tested & used by 1M+ professionals
Superhuman AI newsletter (3 min daily) so you keep learning new AI tools & tutorials to stay ahead in your career—the prompts are just the beginning
The Key to This $240B Market Is in Your Bloodstream
Every year, $240B is spent on treating the symptoms of osteoarthritis, yet not a single therapy has stopped it. Cytonics not only discovered why, they found an answer hiding inside the human body all along. Their first-generation therapy has already treated 10,000+ patients. Now they're pushing a 200% more potent version toward FDA approval. Claim a piece as an early-stage investor today.
This is a paid advertisement for Cytonics Regulation CF offering. Please read the offering circular at https://cytonics.com/